Zhengye Biotechnology Holding Limited (ZYBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 25,531 | 29,124 |
| Cost of Goods | 13,023 | 11,256 |
| Gross Profit | 12,508 | 17,868 |
| Operating Expenses | 10,279 | 11,935 |
| Operating Income | 2,252 | 6,189 |
| Interest Expense | 554 | 609 |
| Other Income | 275 | 441 |
| Pre-tax Income | 1,973 | 6,021 |
| Income Tax | 127 | 860 |
| Net Income Continuous | 1,846 | 5,161 |
| Minority Interests | 296 | 833 |
| Net Income | $1,550 | $4,328 |
| EPS Basic Total Ops | 0.03 | 0.09 |
| EPS Basic Continuous Ops | 0.04 | 0.11 |
| EPS Diluted Total Ops | 0.03 | 0.09 |
| EPS Diluted Continuous Ops | 0.04 | 0.11 |
| EPS Diluted Before Non-Recurring Items | 0.03 | N/A |
| EBITDA(a) | $5,562 | $9,479 |